CONMED Corporation

CNMDNYSEHealthcare● Active

$34.99

$-0.18(-0.50%)

Market Cap$1.1B

P/E Ratio—

52W High$60.35

52W Low$32.13

Avg Volume440K

Open$35.19

Beta0.92

Overview

CONMED Corporation (CNMD) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CNMD · free cash flow · updated Jun 8, 2026

Core FCF metrics

CNMD · FCF · TTM · margin & CAGR

Free cash flow was $150.9M for FY2025 (fiscal year ending 2025-12-31), down 2.0% year-over-year The FCF margin was 11.0%. Five-year CAGR stands at +24.0%.

FY2025 Free Cash Flow$150.9M▼ -2.0% YoY

Trailing 12M (TTM)$123.7Mtrailing 4 quarters sum

FCF Margin11.0%$150.9M ÷ revenue

3-Year CAGR+135.3%FY2022 → FY2025

5-Year CAGR+24.0%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CNMD · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$170.7M(20M)$150.9M▼ 2.0%11.0%

FY2024$167.0M(13M)$153.9M▲ +44.7%11.8%

FY2023$125.3M(19M)$106.3M▲ +818.1%8.5%

FY2022$33.4M(22M)$11.6M▼ 88.1%1.1%

FY2021$111.8M(15M)$96.9M▲ +88.1%9.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CNMD · P/FCF · FCF yield · FCF per share

CONMED Corporation (CNMD) trades at a FCF yield of 11.75% and a price-to-free-cash-flow ratio of 8.8x. FCF per share stands at $3.99, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

11.75%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.99

TTM FCF ÷ Shares Outstanding

Price / FCF

x8.8

Share Price ÷ FCF per Share

EV / FCF (TTM)

x15.2

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CNMD · cash flow statement · operating / investing / financing

For FY2025, CONMED Corporation generated $170.7M in operating cash flow and spent 20M in capital expenditures, yielding $150.9M in free cash flow.

Operating Activities

+$170.7M

Cash from core business operations

2025-12-31

Investing Activities

−$21.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$135.8M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($170.7M) − |CapEx| (20M) = FCF ($150.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CNMD vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CONMED CorporationYOU

CNMD

$150.9M-2.0%11.0%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CONMED Corporation (CNMD) reported free cash flow of $150.9M for FY2025 (fiscal year ending 2025-12-31), down 2.0% year-over-year. The FCF margin was 11.0%.

Based on available data, CONMED Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $153.9M in FY2024. The 5-year CAGR stands at +24.0%.

CONMED Corporation's FCF yield is 11.75% and price-to-FCF ratio is 8.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CNMD free cash flow · 8 questions

CONMED Corporation free cash flow was $150.9M for FY2025, down 2.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $123.7M.

CNMD free cash flowCNMD FCFCNMD FCF 2025CNMD free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CONMED Corporation · CONMED Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026